Share this post on:

Product Name :
Milvexian

Search keywords :
Milvexian

drugId :
null

Target Vo:
Coagulation factor XI

Target Vo Short Name :
F11

Moa_Name:
Factor XIa inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :
Almac Clinical Services

Active Indication_Name:
Atrial Fibrillation

In Active Indication_Name:
Kidney Diseases

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-STAT3 (Tyr705) Rabbit pAb web
Fatty Acid Synthase Rabbit mAb medchemexpress
Transferrin Antibody (YA840): Transferrin Antibody (YA840) is a non-conjugated and Mouse origined monoclonal antibody about 77 kDa. It can be used for WB,IHC-P,ICC/IF assays in the background of Human.

Share this post on:

Author: Interleukin Related